Cryofocus Medtech (Shanghai) Co., Ltd.

SEHK:6922 Stock Report

Market Cap: HK$2.4b

Cryofocus Medtech (Shanghai) Balance Sheet Health

Financial Health criteria checks 4/6

Cryofocus Medtech (Shanghai) has a total shareholder equity of CN¥173.5M and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥212.8M and CN¥39.4M respectively.

Key information

0%

Debt to equity ratio

CN¥0

Debt

Interest coverage ration/a
CashCN¥104.46m
EquityCN¥173.46m
Total liabilitiesCN¥39.36m
Total assetsCN¥212.82m

Recent financial health updates

Recent updates

We're Not Very Worried About Cryofocus Medtech (Shanghai)'s (HKG:6922) Cash Burn Rate

Jan 10
We're Not Very Worried About Cryofocus Medtech (Shanghai)'s (HKG:6922) Cash Burn Rate

Cryofocus Medtech (Shanghai) (HKG:6922) Is In A Good Position To Deliver On Growth Plans

Oct 03
Cryofocus Medtech (Shanghai) (HKG:6922) Is In A Good Position To Deliver On Growth Plans

Companies Like Cryofocus Medtech (Shanghai) (HKG:6922) Are In A Position To Invest In Growth

May 30
Companies Like Cryofocus Medtech (Shanghai) (HKG:6922) Are In A Position To Invest In Growth

Financial Position Analysis

Short Term Liabilities: 6922's short term assets (CN¥149.9M) exceed its short term liabilities (CN¥30.8M).

Long Term Liabilities: 6922's short term assets (CN¥149.9M) exceed its long term liabilities (CN¥8.6M).


Debt to Equity History and Analysis

Debt Level: 6922 is debt free.

Reducing Debt: 6922 has not had any debt for past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Insufficient data to determine if 6922 has enough cash runway based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if 6922 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.